Volume 2 Number 3
Editorial
50
What is the outcome of mother and child after percutaneous mitral valvuloplasty performed during pregnancy?EuroInterv.2006;2:280-281
EAPCI column
52
European Association of Percutaneous Cardiovascular Interventions (EAPCI)EuroInterv.2006;2:284-285
Clinical research
53
A randomised comparison of an everolimus-eluting coronary stent with a paclitaxel-eluting coronary stent: the SPIRIT II trialSerruys PW, Ruygrok P, Neuzner J, Piek J, Seth A, Schofer J, Richardt G, Wiemer M, Carrié D, Thuesen L, Boone E, Miquel-Herbert K, Daemen J
EuroInterv.2006;2:286-294
54
The randomised study of the double dose versus single dose sirolimus-eluting stent for the treatment of diabetic patients with de novo coronary lesionsCosta RA, Eduardo Sousa J, Abizaid A, Chaves A, Feres F, Sousa A, Musumeci G, Mehran R, Fitzgerald P, Lansky AJ, Leon MB, Shiran A, Halon D, Lewis B, Guagliumi G
EuroInterv.2006;2:295-301
55
Long term outcome of balloon mitral commissurotomy during pregnancy: a prospective physical and mental evaluation of babiesGamra H, Ben-Farhat M, Betbout F, Addad F, Ben-Rejeb R, Dridi Z, Khedher S, Ben-Hamda K, Maatouk F, Maaoui S
EuroInterv.2006;2:302-309
56
Biodegradable-Polymer-Based, Paclitaxel-Eluting Infinnium™ Stent: 9-Month clinical and angiographic follow-up results from the SIMPLE II prospective multi-centre registry studyVranckx P, Serruys PW, Gambhir S, Eduardo Sousa J, Abizaid A, Lemos P, Ribeiro E, Dani SI, Dalal JJ, Mehan V, Dhar A, Dutta AL, Reddy KN, Chand R, Ray A, Symons J, for the SIMPLE II study team
EuroInterv.2006;2:310-317
58
Percutaneous Patent Foramen Ovale (PFO) closure in young patients with both cryptogenic brain infarction and PFO associated with Atrial Septal Aneurysm (ASA)Juliard J-M, Abboud H, Aubry P, Brochet E, Sauguet A, Depoix JP, Philip Y, Messika-Zeitoun D, Lung B, Vahanian A, Amarenco P
EuroInterv.2006;2:326-329
59
Two-year clinical follow-up of the unrestricted use of the paclitaxel-eluting stent compared to the sirolimus-eluting stent as part of the Taxus-Stent Evaluated at Rotterdam Cardiology Hospital (T-SEARCH) registryDaemen J, Tsuchida K, Stefanini GG, Vaina S, Kukreja N, de Jaegere P, Ong ATL, van Domburg RT, Serruys PW
EuroInterv.2006;2:330-337
60
Virtual histology and remodelling index allow in vivo identification of allegedly high-risk coronary plaques in patients with acute coronary syndromes: a three vessel intravascular ultrasound radiofrequency data analysisGarcía-García H, Goedhart D, Schuurbiers JCH, Kukreja N, Tanimoto S, Daemen J, Morel M-A, Bressers M, van Es GA, Wentzel J, Gijsen F, van der Steen A, Serruys PW
EuroInterv.2006;2:338-344
61
Human myocardium preconditioning during successive balloon inflations: irrelevant influence of both collateral recruitment and clinical pre-intervention interferencePimentel WA, Ambrose J, Mathias W, Arruda A, Horta P, Ribeiro E, Esteves-Filho A, Lemos P, Ramires J
EuroInterv.2006;2:345-350
62
Incidence of procedural related myocardial infarction following percutaneous coronary intervention.EuroInterv.2006;2:351-355
63
Sirolimus-Eluting Stents vs Bare Metal Stents for the treatment of unprotected left main coronary artery stenosisEuroInterv.2006;2:356-362
Expert review
65
What is the role for revascularisation in patients being considered for ICD therapy?EuroInterv.2006;2:371-374
How and why
66
The how and why of... Chronic Total Occlusions - Part One: How to treat CTOsEuroInterv.2006;2:375-381
67
The how and why of... Chronic Total Occlusions - Part Two: Why we treat CTOs the way we doEuroInterv.2006;2:382-388
New device
68
Contrast enhancement of coronary arteries in cardiac surgery: a new multispectral stereoscopic camera technique EuroInterv.2006;2:389-394
Technical report
69
The Bedside Celution™ system for isolation of adipose derived regenerative cells EuroInterv.2006;2:395-398
20 years of stenting: a patient's perspective
Image in cardiology
Volume 2 Number 3 has been released thanks to the support of the following partners:
- Abbott Vascular Devices
- Boston Scientific
- Cordis, a Johnson & Johnson company
- Hexacath
- Medtronic
- Terumo



